Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Tango Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 141
- +27 vs. Q2 2025
- Shares held
- 140.0M
- +12.7M (+10.0%) vs. Q2 2025
- Total value
- $1.18B
- +$524.1M (+80.4%) vs. Q2 2025
- New holders
- 37
- 48 more added
- Sold out
- 10
- 35 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Great Lakes Advisors, LLC | 423,851 | $3.56M | 0.03% | +423,851 | New |
| D. E. Shaw & Co., Inc. | 430,379 | $3.62M | 0.00% | +430,379 | New |
| Avoro Capital Advisors LLC | 545,000 | $4.58M | 0.06% | +545,000 | New |
| Northern Trust Corp | 605,561 | $5.09M | 0.00% | +5,053+0.8% | Added |
| Charles Schwab Investment Management Inc | 658,292 | $5.53M | 0.00% | +56,845+9.5% | Added |
| Dimensional Fund Advisors LP | 672,735 | $5.65M | 0.00% | +147,637+28.1% | Added |
| ArrowMark Colorado Holdings LLC | 708,385 | $5.95M | 0.11% | 00.0% | Unchanged |
| Bessemer Group Inc | 708,398 | $5.95M | 0.01% | +140.0% | Added |
| Candriam Luxembourg S.C.A. | 708,812 | $5.95M | 0.03% | 00.0% | Unchanged |
| Vivo Capital, LLC | 776,699 | $6.52M | 0.53% | +176,699+29.4% | Added |
| Franklin Resources Inc | 926,904 | $7.79M | 0.00% | +801,697+640.3% | Added |
| Nuveen, LLC | 928,012 | $7.80M | 0.00% | +485,049+109.5% | Added |
| Logos Global Management LP | 950,000 | $7.98M | 0.79% | +950,000 | New |
| Invesco Ltd. | 1,031,917 | $8.67M | 0.00% | +936,624+982.9% | Added |
| Millennium Management LLC | 1,295,401 | $10.9M | 0.01% | −476,903−26.9% | Reduced |
| Deep Track Capital, LP | 1,454,562 | $12.2M | 0.34% | +1,454,562 | New |
| Marshall Wace, LLP | 1,489,518 | $12.5M | 0.01% | −253,173−14.5% | Reduced |
| Commodore Capital LP | 1,500,000 | $12.6M | 0.62% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,509,475 | $12.7M | 0.00% | +1,401,296+1,295.3% | Added |
| Nantahala Capital Management, LLC | 1,809,948 | $15.2M | 0.94% | −1,629,646−47.4% | Reduced |
| Geode Capital Management, LLC | 1,882,777 | $15.8M | 0.00% | +113,864+6.4% | Added |
| Ra Capital Management, L.P. | 2,000,000 | $16.8M | 0.21% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,302,274 | $19.3M | 0.01% | +2,302,274 | New |
| Adage Capital Partners GP, L.L.C. | 2,511,000 | $21.1M | 0.03% | −3,394,349−57.5% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 2,712,008 | $22.8M | 1.51% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,919,450 | $24.5M | 0.05% | +2,919,450 | New |
| Paradigm Biocapital Advisors LP | 3,086,184 | $25.9M | 0.77% | +3,086,184 | New |
| State Street Corp | 3,365,205 | $28.3M | 0.00% | +1,982,519+143.4% | Added |
| Balyasny Asset Management LLC | 3,472,207 | $29.2M | 0.06% | +224,744+6.9% | Added |
| T. Rowe Price Investment Management, Inc. | 3,526,359 | $29.6M | 0.02% | +357,133+11.3% | Added |
| Gilead Sciences, Inc. | 4,854,443 | $40.8M | 2.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 5,052,003 | $42.4M | 0.00% | +1,025,203+25.5% | Added |
| Nextech Invest, Ltd. | 5,533,980 | $46.5M | 7.08% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,646,919 | $47.4M | 0.00% | +183,653+3.4% | Added |
| Siren, L.L.C. | 5,883,188 | $49.4M | 1.93% | +2,518,374+74.8% | Added |
| Woodline Partners LP | 6,029,928 | $50.7M | 0.24% | +220.0% | Added |
| TCG Crossover Management, LLC | 8,536,196 | $71.7M | 3.53% | −2,199,804−20.5% | Reduced |
| Boxer Capital Management, LLC | 9,771,485 | $82.1M | 26.16% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 10,630,736 | $89.3M | 4.29% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 10,757,000 | $90.4M | 0.51% | +1,600,000+17.5% | Added |
| TRV GP IV, LLC | 13,863,975 | $116.5M | 42.51% | −2,995,100−17.8% | Reduced |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −218,779−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −210,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −81,953−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −56,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −55,806−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −55,065−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −49,901−100.0% | Sold out |
| Allostery Investments LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Northeast Financial Consultants Inc | – | – | – | – | Not filed |